The pathophysiology of falciparum malaria

Pharmacology and Therapeutics

Volumn 99, Issue 2, 2003, Pages 221-260

  Clark, Ian A ^a   Cowden, William B ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b Biology and Environment   (Australia)

Author keywords

Malaria; Na+ K+ ATPase; Nitric oxide; Poly(ADP ribose) polymerase; Sepsis; Tumor necrosis factor

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BACTERIAL TOXIN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOTOXIN; MIGRATION INHIBITION FACTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN RADICAL; SALICYLIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR;

ANEMIA; BACTERIAL IMMUNITY; BIOENERGY; CELLULAR IMMUNITY; CONSCIOUSNESS DISORDER; ENZYME ACTIVATION; ERYTHROCYTE; FATALITY; HUMAN; HYPERKALEMIA; HYPERLACTATEMIA; HYPOGLYCEMIA; HYPONATREMIA; HYPOXIA; INFECTION; MALARIA FALCIPARUM; METABOLIC ACIDOSIS; OUTCOMES RESEARCH; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PARASITE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; SEPSIS; TOXICITY; VACCINATION;

EID: 0042346427     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(03)00060-3     Document Type: Review

References (466)

1. Abdalla S., Weatherall D.J., Wickramasinghe S.N., Hughes M. The anaemia of P. falciparum malaria. Br J Haematol. 46:1980;171-183.
2. Abdelkarim G.E., Gertz K., Harms C., Katchanov J., Dirnagl U., Szabo C., Endres M. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Int J Mol Med. 7:2001;255-260.
3. Abernathy R.S., Bradley G.M., Spink W.W. Increased susceptibility of mice with brucellosis to bacterial endotoxins. J Immunol. 81:1958;271-275.
4. Abraham E., Anzueto A., Gutierrez G., Tessler S., Sanpedro G., Wunderink R., Dalnogare A., Nasraway S., Berman S., Cooney R., Levy H., Baughman R., Rumbak M., Light R.B., Poole L., Allred R., Constant J., Pennington J., Porter S. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. Lancet. 351:1998;929-933.
5. Adams S., Brown H., Turner G. Breaking down the blood-brain barrier: signaling a path to cerebral malaria? Trends Parasitol. 18:2002;360-366.
6. Agbenyega T., Angus B., Beduaddo G., Baffoebonnie B., Griffin G., Vallance P., Krishna S. Plasma nitrogen oxides and blood lactate concentrations in Ghanaian children with malaria. Trans R Soc Trop Med Hyg. 91:1997;298-302.
7. Aggarwal B.B., Moffat B., Harkins R.N. Human lymphotoxin: production by a lymphoblastoid cell line, purification and initial characterization. J Biol Chem. 259:1984;686-691.
8. Aggarwal B.B., Kohr W.J., Hass P.E., Moffat B., Spencer S.A., Henzel W.J., Bringman T.S., Nedwin G.E., Goeddel D.V., Harkins R.N. Human tumor necrosis factor: production, purification, and characterization. J Biol Chem. 260:1985;2345-2354.
9. Aikawa M., Iseki M., Barnwell J.W., Taylor D., Oo M.M., Howard R.J. The pathology of human cerebral malaria. Am J Trop Med Hyg. 43:1990;30-37. (Suppl.).
10. Altschule M.D., Freedberg A.S., McManus M.J. Circulation and respiration during an episode of chill and fever in man. J Clin Invest. 24:1945;878-889.
11. Al Yaman F., Awburn M.M., Clark I.A. Serum creatinine levels and reactive nitrogen intermediates in children with cerebral malaria in Papua New Guinea. Trans R Soc Trop Med Hyg. 91:1997;303-305.
12. Annane D., Sanquer S., Sebille V., Faye A., Djuranovic D., Raphael J.C., Gajdos P., Bellissant E. Compartmentalised inducible nitric-oxide synthase activity in septic shock. Lancet. 355:2000;1143-1148.
13. Anstey N.M., Weinberg J.B., Hassanali M., Mwaikambo E.D., Manyenga D., Misukonis M.A., Arnelle D.R., Hollis D., Mcdonald M.I., Granger D.L. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med. 184:1996;557-567.
14. Anstey N.M., Granger D.L., Hassanali M.Y., Mwaikambo E.D., Duffy P.E., Weinberg J.B. Nitric oxide, malaria, and anemia: Inverse relationship between nitric oxide production and hemoglobin concentration in asymptomatic, malaria-exposed children. Am J Trop Med Hyg. 61:1999;249-252.
15. Arbuse D.I. Neuropsychiatric manifestation in malaria. Nav Med Bull. 45:1945;309-403.
16. Arcuri F., Ricci C., Ietta F., Cintorino M., Tripodi S.A., Cetin I., Garzia E., Schatz F., Klemi P., Santopietro R., Paulesu L. Macrophage migration inhibitory factor in the human endometrium: Expression and localization during the menstrual cycle and early pregnancy. Biol Reprod. 64:2001;1200-1205.
17. Babiychuk E., Cottrill P.B., Storozhenko S., Fuangthong M., Chen Y., O'Farrell M.K., Van Montagu M., Inze D., Kushnir S. Higher plants possess two structurally different poly(ADP-ribose) polymerases. Plant J. 15:1998;635-645.
18. Balon T.W., Nadler J.L. Nitric oxide mediates skeletal glucose transport. Am J Physiol. 33:1996;E1058-E1064.
19. Barthlen W., Klemens C., Rogenhofer S., Stadler J., Unbehaun N., Holzmann B. Critical role of nitric oxide for proliferation and apoptosis of bone-marrow cells under septic conditions. Ann Hematol. 79:2000;249-254.
20. Bate C.A., Kwiatkowski D. Inhibitory immunoglobulin m antibodies to tumor necrosis factor-inducing toxins in patients with malaria. Infect Immun. 62:1994;3086-3091.
21. Bate C.A.W., Taverne J., Playfair J.H.L. Malarial parasites induce TNF production by macrophages. Immunology. 64:1988;227-231.
22. Bate C.A.W., Taverne J., Dave A., Playfair J.H.L. Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF. Immunology. 70:1990;315-320.
23. Bate C.A., Taverne J., Bootsma H.J., Mason R.C., Skalko N., Gregoriadis G., Playfair J.H. Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens. Immunology. 76:1992;35-41.
24. Bate C.A., Taverne J., Playfair J.H. Detoxified exoantigens and phosphatidylinositol derivatives inhibit tumor necrosis factor induction by malarial exoantigens. Infect Immun. 60:1992;1894-1901.
25. Bateman R.M., Jagger J.E., Sharpe M.D., Ellsworth M.L., Mehta S., Ellis C.G. Erythrocyte deformability is a nitric oxide-mediated factor in decreased capillary density during sepsis. Am J Physiol. 280:2001;H2848-H2856.
26. Baumgartner R.W., Bartsch P., Maggiorini M., Waber U., Oelz O. Enhanced cerebral blood flow in acute mountain sickness. Aviat Space Environ Med. 65:1994;726-729.
27. Beckman J.S., Crow J.P. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans. 21:1993;330-334.
28. Bedard S., Marcotte B., Marette A. Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase. Biochem J. 325:1997;487-493.
29. Beishuizen A., Thijs L.G., Haanen C., Vermes I. Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab. 86:2001;2811-2816.
30. Bell R.W. Ophthalmologic findings in malaria. Ann Ophthalmol. 7:1975;1439-1442.
31. Benaceraff B., Thorbecke G.J., Jacoby D. Effect of zymosan on endotoxin toxicity in mice. Proc Soc Exp Biol Med. 100:1959;796.
32. Berendt A.R., Turner G.D.H., Newbold C.I. Cerebral malaria: The sequestration hypothesis. Parasitol Today. 10:1994;412-414.
33. Berger N.A., Berger S.J. Metabolic consequences of DNA damage: the role of poly (ADP-ribose) polymerase as mediator of the suicide response. Basic Life Sci. 38:1986;357-363.
34. Bernhagen J., Calandra T., Mitchell R.A., Martin S.B., Tracey K.J., Voelter W., Manogue K.R., Cerami A., Bucala R. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature. 365:1993;756-759.
35. Bersten A., Sibbald W.J. Circulatory disturbances in multiple systems organ failure. Crit Care Clin. 5:1989;233-254.
36. Betrosian A., Thireos E., Kofinas G., Balla M., Papanikolaou M., Georgiadis G. Bacterial sepsis-induced rhabdomyolysis. Intensive Care Med. 25:1999;469-474.
37. Beutler B., Greenwald D., Hulmes J.D., Chang M., Pan Y.-C., Mathison J., Ulevitch R., Cerami A. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature. 316:1985;552-554.
38. Beutler B., Milsark I.W., Cerami A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science. 229:1985;869-871.
39. Beutler B.A., Milsark I.W., Cerami A. Cachectin/tumor necrosis factor: Production, distribution, and metabolic fate in vivo. J Immunol. 135:1985;3972-3977.
40. Biemba G., Gordeuk V.R., Thuma P., Weiss G. Markers of inflammation in children with severe malarial anaemia. Trop Med Int Health. 5:2000;256-262.
41. Bihari D., Smithies M., Gimson A., Tinker J. The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. N Engl J Med. 317:1987;397-403.
42. Billiau A., Leyton R., Vandeputte M., De Somer P. Inhibition of development of mammary tumours in C3H mice by neonatal administration of polycarboxylate. Life Sci. 10:1971;643-648.
43. Binh T.Q., Davis T.M.E., Johnston W., Thu L.T.A., Boston R., Danh P.T., Anh T.K. Glucose metabolism in severe malaria: Minimal model analysis of the intravenous glucose tolerance test incorporating a stable glucose label. Metab Clin Exp. 46:1997;1435-1440.
44. Bird T.A., Davies A., Baldwin S.A., Saklatvala J. Interleukin-1 stimulates hexose transport in fibroblasts by increasing the expression of glucose transporters. J Biol Chem. 265:1990;13578-13583.
45. Bloom B.R., Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 153:1966;80-82.
46. Boczkowski J., Lanone S., Ungureanulongrois D., Danialou G., Fournier T., Aubier M. Induction of diaphragmatic nitric oxide synthase after endotoxin administration in rats - role in diaphragmatic contractile dysfunction. J Clin Invest. 98:1996;1550-1559.
47. Boczkowski J., Lisdero C.L., Lanone S., Samb A., Carreras M.C., Boveris A., Aubier M., Poderoso J.J. Endogenous peroxynitrite mediates mitochondrial dysfunction in rat diaphragm during endotoxemia. FASEB J. 13:1999;1637-1646.
48. Boekstegers P., Weidenhofer S., Kapsner T., Werdan K. Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit Care Med. 22:1994;640-650.
49. Bone R.C. The pathogenesis of sepsis. Ann Intern Med. 115:1991;457-469.
50. Boutlis C.S., Gowda D.C., Naik R.S., Maguire G.P., Mgone C.S., Bockarie M.J., Lagog M., Ibam E., Lorry K., Anstey N.M. Antibodies to Plasmodium falciparum glycosylphosphatidylinositols: Inverse association with tolerance of parasitemia in Papua New Guinean children and adults. Infect Immun. 70:2002;5052-5057.
51. Brealey D., Brand M., Hargreaves I., Heales S., Land J., Smolenski R., Davies N.A., Cooper C.E., Singer M. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 360:2002;219-223.
52. Brewster D., Hill A.V.S., Kwiatkowski D., Greenwood B. Hypoglycaemia and cerebral malaria. Lancet. 336:1990;951-952.
53. Bringman T.S., Aggarwal B.B. Monoclonal antibodies to human tumor necrosis factors alpha and beta: application for affinity purification, immunoassays, and as structural probes. Hybridoma. 6:1987;489-507.
54. Brown J., Greenwood B.M., Terry R.J. Cellular mechanisms involved in recovery from acute malaria in Gambian children. Parasite Immunol. 8:1986;551-564.
55. Brown H., Hien T.T., Day N., Mai N., Chuong L.V., Chau T., Loc P.P., Phu N.H., Bethell D., Farrar J., Gatter K., White N., Turner G. Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol. 25:1999;331-340.
56. Brown H., Rogerson S., Taylor T., Tembo M., Mwenechanya J., Molyneux M., Turner G. Blood-brain barrier function in cerebral malaria in Malawian children. Am J Trop Med Hyg. 64:2001;207-213.
57. Butcher G.A., Garland T., Adjukiewicz A.B., Clark I.A. Serum TNF associated with malaria in patients in the Solomon Islands. Trans R Soc Trop Med Hyg. 84:1990;658-661.
58. Butler T., Ho M., Acharya G., Tiwari M., Gallati H. Interleukin-6, gamma interferon, and tumor necrosis factor receptors in typhoid fever related to outcome of antimicrobial therapy. Antimicrob Agents Chemother. 37:1993;2418-2421.
59. +ATPase. Eur J Neurosci. 7:1995;1674-1683.
60. Calandra T., Bucala R. Macrophage migration inhibitory factor - a counter-regulator of glucocorticoid action and critical mediator of septic shock. J Inflam. 47:1996;39-51.
61. Calandra T., Bernhagen J., Mitchell R.A., Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med. 179:1994;1895-1902.
62. Calandra T., Echtenacher B., Le Roy D., Pugin J., Metz C.N., Hultner L., Heumann D., Mannel D., Bucala R., Glauser M.P. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med. 6:2000;164-170.
63. Callahan L.A., Nethery D., Stofan D., DiMarco A., Supinski G. Free radical-induced contractile protein dysfunction in endotoxin-induced sepsis. Am J Respir Cell Mol Biol. 24:2001;210-217.
64. Cannon P.R. Some pathological aspects of human malaria. Moulton F.R. A Symposium on Human Malaria. 1941;214-220 American Association for the Advancement of Science, Washington.
65. Carswell E.A., Old L.J., Kassel R.L., Green S., Fiore N., Williamson B. An endotoxin induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA. 72:1975;3666-3670.
66. Castro L., Rodriguez M., Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem. 269:1994;29409-29415.
67. Chaiyaroj S.C., Angkasekwinai P., Buranakiti A., Looareesuwan S., Rogerson S.J., Brown G.V. Cytoadherence characteristics of Plasmodium falciparum isolates from Thailand - evidence for chondroitin sulfate a as a cytoadherence receptor. Am J Trop Med Hyg. 55:1996;76-80.
68. Chen L.-C., Kepka-Lenhart D., Wright T.M., Morris S.M. Jr. Salicylate-enhanced activation of transcription factors induced by interferon-γ Biochem J. 432:1999;503-507.
69. Chiarugi A. Poly(ADP-ribose) polymerase: Killer or conspirator? The "suicide hypothesis" revisited. Trends Pharmacol Sci. 23:2002;122-129.
70. Chinnaiyan A.M., Huber-Lang M., Kumar-Sinha C., Barrette T.R., Shankar-Sinha S., Sarma V.J., Padgaonkar V.A., Ward P.A. Molecular signatures of sepsis - multiorgan gene expression profiles of systemic inflammation. Am J Pathol. 159:2001;1199-1209.
71. Clark I.A. Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis? Lancet. ii:1978;75-77.
72. Clark I.A. Protection of mice against Babesia microti with cord factor, COAM, zymosan, glucan, Salmonella and Listeria. Parasite Immunol. 1:1979;179-196.
73. Clark I.A. Resistance to Babesia spp. and Plasmodium sp. in mice pretreated with an extract of Coxiella burnetii. Infect Immun. 24:1979;319-325.
74. Clark I.A. Correlation between susceptibility to malaria and babesia parasites and to endotoxin. Trans R Soc Trop Med Hyg. 76:1982;4-7.
75. Clark I.A. Suggested importance of monokines in pathophysiology of endotoxin shock and malaria. Klin Wochenschr. 60:1982;756-758.
76. Clark I.A. Cell-mediated immunity in protection and pathology of malaria. Parasitol Today. 3:1987;300-305.
77. Clark I.A., Chaudhri G. Tumor necrosis factor in malaria-induced abortion. Am J Trop Med Hyg. 39:1988;246-249.
78. Clark I.A., Chaudhri G. Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br J Haematol. 70:1988;99-103.
79. Clark I.A., Chaudhri G. Inflammation and parasitic disease. de Sousa M., Brock J. Iron in Immunity, Cancer and Inflammation. 1989;177-195 Wiley, Chichester.
80. Clark I.A., Cowden W.B. Why is the pathology of falciparum worse than that of vivax malaria? Parasitol Today. 15:1999;458-461.
81. Clark I.A., Hunt N.H. Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria. Infect Immun. 39:1983;1-6.
82. Clark I.A., Rockett K.A. Immunizing against toxic malarial antigens. Parasitol Today. 10:1994;6.
83. Clark I.A., Rockett K.A. The cytokine theory of human cerebral malaria. Parasitol Today. 10:1994;410-412.
84. Clark H.C., Tomlinson W.J. The pathologic anatomy of malaria. Boyd M.F. Malariology. vol. II:1949;874-903 W.B. Saunders, Philadelphia.
85. Clark I.A., Allison A.C., Cox F.E. Protection of mice against Babesia and Plasmodium with BCG. Nature. 259:1976;309-311.
86. Clark I.A., Cox F.E., Allison A.C. Protection of mice against Babesia spp. and Plasmodium spp. with killed Corynebacterium parvum. Parasitology. 74:1977;9-18.
87. Clark I.A., Richmond J.E., Wills E.J., Allison A.C. Intra-erythrocytic death of the parasite in mice recovering from infection with Babesia microti. Parasitology. 75:1977;189-196.
88. Clark I.A., Wills E.J., Richmond J.E., Allison A.C. Suppression of babesiosis in BCG-infected mice and its correlation with tumor inhibition. Infect Immun. 17:1977;430-438.
89. Clark I.A., Virelizier J.-L., Carswell E.A., Wood P.R. Possible importance of macrophage-derived mediators in acute malaria. Infect Immun. 32:1981;1058-1066.
90. Clark I.A., Cowden W.B., Butcher G.A. Free oxygen radical generators as antimalarial drugs. Lancet. i:1983;234.
91. Clark I.A., Hunt N.H., Cowden W.B., Maxwell L.E., Mackie E.J. Radical-mediated damage to parasites and erythrocytes in Plasmodium vinckei-infected mice after injection of t-butyl hydroperoxide. Clin Exp Immunol. 56:1984;524-530.
92. Clark I.A., Cowden W.B., Hunt N.H. Free radical-induced pathology. Med Res Rev. 5:1985;279-332.
93. Clark I.A., Hunt N.H., Cowden W.B. Oxygen-derived free radicals in the pathogenesis of parasitic disease. Adv Parasitol. 25:1986;1-44.
94. Clark I.A., Cowden W.B., Butcher G.A., Hunt N.H. Possible roles of tumor necrosis factor in the pathology of malaria. Am J Pathol. 129:1987;192-199.
95. Clark I.A., Hunt N.H., Butcher G.A., Cowden W.B. Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-γ or tumor necrosis factor, and its enhancement by butylated hydroxyanisole. J Immunol. 139:1987;3493-3496.
96. Clark I.A., Rockett K.A., Cowden W.B. Proposed link between cytokines, nitric oxide, and human cerebral malaria. Parasitol Today. 7:1991;205-207.
97. Clark I.A., Gray K.M., Rockett E.J., Cowden W.B., Rockett K.A., Ferrante A., Aggarwal B.B. Increased lymphotoxin in human malarial serum, and the ability of this cytokine to increase plasma interleukin-6 and cause hypoglycaemia in mice - implications for malarial pathology. Trans R Soc Trop Med Hyg. 86:1992;602-607.
98. Clark I.A., Rockett K.A., Cowden W.B. Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet. 340:1992;894-896.
99. Clark I.A., Whitten R.O., Molyneux M.E., Taylor T.E. Salicylates, nitric oxide, malaria, and Reye's syndrome. Lancet. 357:2001;625-627.
100. Clark I.A., Awburn M.M., Whitten R.O., Harper C.G., Liomba N.G., Molyneux M.E., Taylor T.E. Tissue distribution of migration inhibitory factor and inducible nitric oxide synthase in falciparum malaria and sepsis in African children. Malaria J. 2(6):2003.
101. Clavier N., Rahimy C., Falanga P., Ayivi B., Payen D. No evidence for cerebral hypoperfusion during cerebral malaria. Crit Care Med. 27:1999;628-632.
102. Cleeter M.W., Cooper J.M., Darley-Usmar V.M., Moncada S., Schapira A.H. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett. 345:1994;50-54.
103. Coleman R.M., Bruce A., Rencricca N.J. Malaria: Macrophage migration inhibitory factor (MIF). J Parasitol. 62:1976;137-138.
104. Collins F.M., Scott M.T. Effect of Corynebacterium parvum on the growth of Salmonella enteritidis in mice. Infect Immun. 9:1974;863-869.
105. Cooke B.M., Nicoll C.L., Baruch D.I., Coppel R.L. A recombinant peptide based on PfEMP-1 blocks and reverses adhesion of malaria-infected red blood cells to CD36 under flow. Mol Microbiol. 30:1998;83-90.
106. Cosi C. New inhibitors of poly(ADPribose) polymerase and their potential therapeutic targets. Expert Opin Ther Pat. 12:2002;1047-1071.
107. Cox F.E. Protective immunity between malaria parasites and piroplasms in mice. Bull World Health Organ. 43:1970;325-336.
108. Cox F.E., Young A.S. Acquired immunity to Babesia microti and Babesia rodhaini in mice. Parasitology. 59:1969;257-268.
109. Coxon R.E., Fekade D., Knox K., Hussein K., Melka A., Daniel A., Griffin G.G., Warrell D.A. The effect of antibody against TNF alpha on cytokine response in Jarisch-Herxheimer reactions of louse-borne relapsing fever. Q J Med. 90:1997;213-221.
110. Craig A.G., Pinches R., Khan S., Roberts D.J., Turner G.D.H., Newbold C.I., Berendt A.R. Failure to block adhesion of Plasmodium falciparum-infected erythrocytes to ICAM-1 with soluble ICAM-1. Infect Immun. 65:1997;4580-4585.
111. Creagan E.T., Kovach J.S., Moertel C.G., Frytak S., Kvols L.K. A phase I clinical trial of recombinant human tumor necrosis factor. Cancer. 62:1988;2467-2471.
112. Cuzzocrea S., Filippelli A., Zingarelli B., Falciani M., Caputi A.P., Rossi F. Role of nitric oxide in a nonseptic shock model induced by zymosan in the rat. Shock. 7:1997;351-357.
113. Cuzzocrea S., Zingarelli B., Costantino G., Sottile A., Teti D., Caputi A.P. Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat. Crit Care Med. 27:1999;1517-1523.
114. Das B.S., Nanda N.K. Evidence for erythrocyte lipid peroxidation in acute falciparum malaria. Trans R Soc Trop Med Hyg. 93:1999;58-62.
115. Das B.S., Mohanty S., Mishra S.K., Patnaik J.K., Satpathy S.K., Mohanty D., Bose T.K. Increased cerebrospinal fluid protein and lipid peroxidation products in patients with cerebral malaria. Trans R Soc Trop Med Hyg. 85:1991;733-734.
116. Das B.S., Patnaik J.K., Mohanty S., Mishra S.K., Mohanty D., Satpathy S.K., Bose T.K. Plasma antioxidants and lipid peroxidation products in falciparum malaria. Am J Trop Med Hyg. 49:1993;720-725.
117. Datta S., Patterson E.H., Siwek D.F. Endogenous and exogenous nitric oxide in the pedunculopontine tegmentum induces sleep. Synapse. 27:1997;69-78.
118. David J. Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA. 56:1966;72-77.
119. Davis T.M., Pongponratan E., Supanaranond W., Pukrittayakamee S., Helliwell T., Holloway P., White N.J. Skeletal muscle involvement in falciparum malaria: Biochemical and ultrastructural study. Clin Infect Dis. 29:1999;831-835.
120. Dazord L., Le Garrec Y., David C., Toujas L. Resistance to transplanted cancer in mice increased by live Brucella vaccine. Br J Cancer. 38:1978;464-467.
121. DeForge L.E., Nguyen D.T., Kunkel S.L., Remick D.G. Regulation of the pathophysiology of tumor necrosis factor. J Lab Clin Med. 116:1990;429-438.
122. Delley V., Bouvier P., Breslow N., Doumbo O., Sagara I., Diakite M., Mauris A., Dolo A., Rougemont A. What does a single determination of malaria parasite density mean? A longitudinal survey in Mali. Trop Med Int Health. 5:2000;404-412.
123. de Murcia J.M., Niedergang C., Trucco C., Ricoul M., Dutrillaux B., Mark M., Oliver F.J., Masson M., Dierich A., LeMeur M., Walztinger C., Chambon P., de Murcia G. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci USA. 94:1997;7303-7307.
124. Denicoff K.D., Rubinow D.R., Papa M.Z., Simpson C., Seipp C.A., Lotze M.T., Chang A.E., Rosenstein D., Rosenberg S.A. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med. 107:1987;293-300.
125. Dennis S.C., Gevers W., Opie L.H. Protons in ischemia: Where do they come from; where do they go to? J Mol Cell Cardiol. 23:1991;1077-1086.
126. Deshpande S.A., Platt M.P. Association between blood lactate and acid-base status and mortality in ventilated babies. Arch Dis Child. 76:1997;F15-F20.
127. Dickinson J., Heath D., Gonsey J., Williams D. Altitude-related deaths in seven trekkers in the Himalayas. Thorax. 38:1983;646-656.
128. Di Luzio N.R., Williams D.L. Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice. Infect Immun. 20:1978;804-810.
129. Dobbie M.S., Hurst R.D., Klein N.J., Surtees R. Upregulation of intercellular adhesion molecule-1 expression on human endothelial cells by tumour necrosis factor-α in an in vitro model of the blood-brain barrier. Brain Res. 830:1999;330-336.
130. Dockrell H.M., Playfair J.H. Killing of Plasmodium yoelii by enzyme-induced products of the oxidative burst. Infect Immun. 43:1984;451-456.
131. Dockrell H.M., Alavi A., Playfair J.H.L. Changes in oxidative burst capacity during murine malaria and the effect of vaccination. Clin Exp Immunol. 66:1986;37-43.
132. Dodoo D., Omer F.M., Todd J., Akanmori B.D., Koram K.A., Riley E.M. Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis. 185:2002;971-979.
133. Dondorp A.M., Angus B.J., Chotivanich K., Silamut K., Ruangveerayuth R., Hardeman M.R., Kager P.A., Vreeken J., White N.J. Red blood cell deformability as a predictor of anemia in severe falciparum malaria. Am J Trop Med Hyg. 60:1999;733-737.
134. Dormer P., Dietrich M., Kern P., Horstmann R.D. Ineffective erythropoiesis in acute human P. falciparum malaria. Blut. 46:1983;279-288.
135. Drapier J.C., Hibbs J.B. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J Immunol. 140:1988;2829-2838.
136. Dubos R.J., Schaedler R.W. Effect of cellular constituents of Mycobacteria on the resistance of mice to heterologous infection. J Exp Med. 106:1957;703-709.
137. Dunn M.J. Alterations in red blood cell sodium transport during malaria. J Clin Invest. 48:1969;674-684.
138. Eliasson M.J., Sampei K., Mandir A.S., Hurn P.D., Traystman R.J., Bao J., Pieper A., Wang Z.Q., Dawson T.M., Snyder S.H., Dawson V.L. Poly (ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med. 3:1997;1089-1095.
139. Endres M., Wang Z.Q., Namura S., Waeber C., Moskowitz M.A. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blood Flow Metab. 17:1997;1143-1151.
140. English M. Life-threatening severe malarial anaemia. Trans R Soc Trop Med Hyg. 94:2000;585-588.
141. English M., Marsh V., Amukoye E., Lowe B., Murphy S., Marsh K. Chronic salicylate poisoning and severe malaria. Lancet. 347:1996;1736-1737.
142. English M., Waruiru C., Amukoye E., Murphy S., Crawley J., Mwangi I., Peshu N., Marsh K. Deep breathing in children with severe malaria - indicator of metabolic acidosis and poor outcome. Am J Trop Med Hyg. 55:1996;521-524.
143. English M.C., Waruiru C., Lightowler C., Murphy S.A., Kirigha G., Marsh K. Hyponatraemia and dehydration in severe malaria. Arch Dis Child. 74:1996;201-205.
144. English M., Waruiru C., Marsh K. Transfusion for respiratory distress in life-threatening childhood malaria. Am J Trop Med Hyg. 55:1996;525-530.
145. English M., Muambi B., Mithwani S., Marsh K. Lactic acidosis and oxygen debt in African children with severe anaemia. Q J Med. 90:1997;563-569.
146. English M., Sauerwein R., Waruiru C., Mosobo M., Obiero J., Lowe B., Marsh K. Acidosis in severe childhood malaria. Q J Med. 90:1997;263-270.
147. Engwerda C.R., Mynott T.L., Sawhney S., De Souza J.B., Bickle Q.D., Kaye P.M. Locally up-regulated lymphotoxin α, not systemic tumor necrosis factor α, is the principle mediator of murine cerebral malaria. J Exp Med. 195:2002;1371-1377.
148. Erecinska M., Silver I.A. Ions and energy in mammalian brain. Prog Neurobiol. 43:1994;37-71.
149. Evans D.A., Jacobs D.O., Wilmore D.W. Tumor necrosis factor enhances glucose uptake by peripheral tissues. Am J Physiol. 257:1989;R1182-R1189.
150. Fahmi H., Charon D., Mondange M., Chaby R. Endotoxin-induced desensitization of mouse macrophages is mediated in part by nitric oxide production. Infect Immun. 63:1995;1863-1869.
151. Fahmi H., Ancuta P., Perrier S., Chaby R. Preexposure of mouse peritoneal macrophages to lipopolysaccharide and other stimuli enhances the nitric oxide response to secondary stimuli. Inflamm Res. 45:1996;347-353.
152. 3-subunit mRNA expression in rat hippocampus. Am J Physiol. 266:1994;C423-C428.
153. Feihl F., Waeber B., Liaudet L. Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol Ther. 91:2001;179-213.
154. Fekade D., Knox K., Hussein K., Melka A., Lalloo D.G., Coxon R.E., Warrell D.A. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor α N Engl J Med. 335:1996;311-315.
155. Fink M.P. Does tissue acidosis in sepsis indicate tissue hypoperfusion? Intensive Care Med. 22:1996;1144-1146.
156. Fink M. Cytopathic hypoxia in sepsis. Acta Anaesthesiol Scand. 110:1997;87-95. Suppl.
157. Fink M.P. Cytopathic hypoxia. A concept to explain organ dysfunction in sepsis. Minerva Anestesiol. 66:2000;337-342.
158. Fink M.P. Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin. 17:2001;219-237.
159. Fisher C.J., Agosti J.M., Opal S.M., Lowry S.F., Balk R.A., Sadoff J.C., Abraham E., Schein R.M.H., Benjamin E. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. N Engl J Med. 334:1996;1697-1702.
160. Fossier P., Blanchard B., Ducrocq C., Leprince C., Tauc L., Baux G. Nitric oxide transforms serotonin into an inactive form and this affects neuromodulation. Neuroscience. 93:1999;597-603.
161. Gardella S., Andrei C., Ferrera D., Lotti L.V., Torrisi M.R., Bianchi M.E., Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3:2002;995-1001.
162. Goldfarb R.D., Marton A., Szabo E., Virag L., Salzman A.L., Glock D., Akhter I., McCarthy R., Parrillo J.E., Szabo C. Protective effect of a novel, potent inhibitor of poly(adenosine 5′-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis. Crit Care Med. 30:2002;974-980.
163. Golgi C. Sull infezione malarica. Arch Sci Med. 10:1886;109-135.
164. Granger D.L., Taintor R.R., Cook J.L., Hibbs J.B. Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration. J Clin Invest. 65:1980;357-370.
165. Grau G.E., Fajardo L.F., Piquet P.-F., Allet B., Lambert P.-H., Vassali P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science. 237:1987;1210-1212.
166. Grau G.E., Taylor T.E., Molyneux M.E., Wirima J.J., Vassalli P., Hommel M., Lambert P.-H. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med. 320:1989;1586-1591.
167. Gray P.W., Aggarwal B.B., Benton C.V., Bringman T.S., Henzel W.J., Jarrett J.A., Leung D.W., Moffatt B., Ng P., Svedersky L.P., Palladino M.A., Nedwin G.A. Cloning and expression of the cDNA for human lymphotoxin: Lymphokine with tumor necrosis activity. Nature. 312:1984;721-724.
168. Green S., Dobrjansky A., Chiasson M.A., Carswell E., Schwartz M.K., Old L.J. Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. J Natl Cancer Inst. 59:1977;1519-1522.
169. Greisman S.E., Young E.J., Workman J.B., Ollodart R.M., Hornick R.B. Mechanisms of endotoxin tolerance. The role of the spleen. J Clin Invest. 56:1975;1597-1607.
170. Greve B., Lehman L.G., Lell B., Luckner D., Schmidt O.R., Kremsner P.G. High oxygen radical production is associated with fast parasite clearance in children with Plasmodium falciparum malaria. J Infect Dis. 179:1999;1584-1586.
171. Griffiths M.J., Ndungu F., Baird K.L., Muller D.P.R., Marsh K., Newton C.R.J.C. Oxidative stress and erythrocyte damage in Kenyan children with severe Plasmodium falciparum malaria. Br J Haematol. 113:2001;486-491.
172. Gunnett C.A., Chu Y., Heistad D.D., Loihl A., Faraci F.M. Vascular effects of LPS in mice deficient in expression of the gene for inducible nitric oxide synthase. Am J Physiol. 44:1998;H416-H421.
173. + absorption across cultured alveolar type II monolayers. Am J Physiol. 274:1998;L369-L377.
174. Gutierrez G., Lund N., Palizas F. Rabbit skeletal muscle PO2 during hypodynamic sepsis. Chest. 99:1991;224-229.
175. +-ATPase by nitric oxide in mouse proximal tubule epithelial cells. J Clin Invest. 95:1995;2083-2088.
176. Gyan B., Troyeblomberg M., Perlmann P., Bjorkman A. Human monocytes cultured with and without interferon-gamma inhibit Plasmodium falciparum parasite growth in vitro via secretion of reactive nitrogen intermediates. Parasitol Immunol. 16:1994;371-375.
177. Gyan B., Kurtzhals J.A.L., Akanmori B.D., Ofori M., Goka B.Q., Hviid L., Behr C. Elevated levels of nitric oxide and low levels of haptoglobin are associated with severe malarial anaemia in African children. Acta Trop. 83:2002;133-140.
178. Haldane J.B.S. Disease and evolution. Ric Sci. 19(Suppl. 1):1949;68-76.
179. Halpern B.N., Biozzi G., Stiffel C., Mouton D. Inhibition of tumour growth by administration of killed Corynebacterium parvum. Nature. 212:1966;853-854.
180. Hammarström A.K.M., Gage P.W. Nitric oxide increases persistent sodium current in rat hippocampal neurons. J Physiol. 520:1999;451-461.
181. Hardy D., Kotlarski I. Resistance of mice to Erhlich ascites tumour after immunisation of mice with live Salmonella interitidis 11RX. Aust J Exp Biol Med Sci. 49:1971;271-279.
182. Hariri R.J., Ghajar J.B.G., Bahramian K., Sharif S., Barie P.S. Alterations in intracranial pressure and cerebral blood volume in endotoxemia. Surg Gynecol Obstet. 176:1993;155-166.
183. Hasibeder W., Germann R., Wolf H.J., Haisjackl M., Hausdorfer H., Riedmann B., Bonatii J., Gruber E., Schwarz B., Waldenberger P., Friesenecker B., Furtner B. Effects of short-term endotoxemia and dopamine on mucosal oxygenation in porcine jejunum. Am J Physiol. 270:1996;G667-G675.
184. Hauschildt S., Scheipers P., Bessler W.G., Mulsch A. Induction of nitric oxide synthase in L929 cells by tumour necrosis factor-alpha is prevented by inhibitors of poly(ADP-ribose) polymerase. Biochem J. 288:1992;255-260.
185. Heistad D.D. What's new in the cerebral microcirculation? Landis Award Lecture. Microcirculation. 8:2001;366-375.
186. Helson L., Green S., Carswell E., Old L.J. Effect of tumour necrosis factor on cultured human melanoma cells. Nature. 258:1975;731-732.
187. Herod E., Clark I.A., Allison A.C. Protection of mice against the haemoprotozoan Babesia microti with Brucella abortus strain 19. Clin Exp Immunol. 31:1978;518-523.
188. Hesse D.G., Tracey K.J., Fong Y., Manogue K.R., Palladino M.A., Cerami A., Shires G.T., Lowry S.F. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet. 166:1988;147-153.
189. Heyman A., Beeson P.B. Influence of various disease states upon the febrile response to intravenous injection of typhoid bacterial pyrogen. J Lab Clin Med. 34:1949;1400-1403.
190. Hibbs J.B. Jr., Vavrin Z., Taintor R.R. L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol. 138:1987;550-565.
191. Hibbs J.B., Taintor R.R., Vavrin Z., Rachlin E.M. Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun. 157:1988;87-94.
192. Hierholzer C., Harbrecht B., Menezes J.M., Kane J., Macmicking J., Nathan C.F., Peitzman A.B., Billiar T.R., Tweardy D.J. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med. 187:1998;917-928.
193. Hinshaw L.B., Tekamp-Olson P., Chang A.C.K., Lee P.A., Taylor F.B., Murray C.K., Peer G.T., Emerson T.E., Passey R.B., Kuo G.C. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNFa). Circ Shock. 30:1990;279-292.
194. Ho M., Singh B., Looareesuwan S., Davis T.M.E., Bunnag D., White N.J. Clinical correlates of in vitro Plasmodium falciparum cytoadherence. Infect Immun. 59:1991;873-878.
195. Ho M., Schollaardt T., Niu X., Looareesuwan S., Patel K.D., Kubes P. Characterization of Plasmodium falciparum-infected erythrocyte and P-selectin interaction under flow conditions. Blood. 91:1998;4803-4809.
196. Hollenberg S.M., Broussard M., Osman J., Parrillo J.E. Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circ Res. 86:2000;774-778.
197. Holst F.G.E., Hemmer C.J., Kern P., Dietrich M. Inappropriate secretion of antidiuretic hormone and hyponatremia in severe falciparum malaria. Am J Trop Med Hyg. 50:1994;602-607.
198. Hotchkiss R.S., Karl I.E. Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA. 267:1992;1503-1510.
199. Hotchkiss R.S., Rust R.S., Dence C.S., Wasserman T.H., Song S.K., Hwang D.R., Karl I.E., Welch M.J. Evaluation of the role of cellular hypoxia in sepsis by the hypoxic marker [18F]fluoromisonidazole. Am J Physiol. 261:1991;R965-R972.
200. Hotez P.J., Le Trang N., Fairlamb A.H., Cerami A. Lipoprotein lipase suppression in 3T3-LI cells by a haemoprotozoan-induced mediator from peritoneal exudate cells. Parasitol Immunol. 6:1984;203-209.
201. Houston C.S., Dickinson J. Cerebral form of high-altitude illness. Lancet. ii:1975;758-761.
202. Howard J.G., Biozzi G., Halpern B.N., Stiffel C., Mouton D. The effect of Mycobacterium tuberculosis (BCG) infection on the resistance of mice to bacterial endotoxin and Salmonella enteritidis infection. Br J Exp Pathol. 40:1959;281-290.
203. Illner H., Shires G.T. Changes in sodium, potassium, and adenosine triphosphate contents of red blood cells in sepsis and septic shock. Circ Shock. 9:1982;259-267.
204. Imamura K., Nishihira J., Suzuki M., Yasuda K., Sasaki S., Kusunoki Y., Tochimaru H., Takekoshi Y. Identification and immunohistochemical localization of macrophage migration inhibitory factor in human kidney. Biochem Mol Biol Int. 40:1996;1233-1242.
205. Ince C., Sinaasappel M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med. 27:1999;1369-1377.
206. Iuvone T., Dacquisto F., Carnuccio R., Dirosa M. Nitric oxide inhibits LPS-induced tumor necrosis factor synthesis in vitro and in vivo. Life Sci. 59:1996;PL207-PL211.
207. Jagtap P., Soriano F.G., Virag L., Liaudet L., Mabley J., Szabo E., Hasko G., Marton A., Lorigados C.B., Gallyas F., Sumegi B., Hoyt D.G., Baloglu E., VanDuzer J., Salzman A.L., Southan G.J., Szabo C. Novel phenanthridinone inhibitors of poly(adenosine 5′-diphosphateribose) synthetase: Potent cytoprotective and antishock agents. Crit Care Med. 30:2002;1071-1082.
208. Jakeman G.N., Saul A., Hogarth W.L., Collins W.E. Anaemia of acute malaria infections in non-immune patients primarily results from destruction of uninfected erythrocytes. Parasitology. 119:1999;127-133.
209. Jakobsen P.H., Morris-Jones S.D., Hviid L., Theander T.G., Hoier-Madsen M., Bayoumi R.A., Greenwood B.M. Anti-phospholipid antibodies in patients with Plasmodium falciparum malaria. Immunology. 79:1993;653-657.
210. Johnson R.A., Waddelow T.A., Caro J., Oliff A., Roodman G.D. Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood. 74:1989;130-138.
211. Kapur S., Bedard S., Marcotte B., Cote C.H., Marette A. Expression of nitric oxide synthase in skeletal muscle: A novel role for nitric oxide as a modulator of insulin action. Diabetes. 46:1997;1691-1700.
212. Karunaweera N.D., Carter R., Grau G.E., Kwiatkowski D., Delgiudice G., Mendis K.N. Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients. Clin Exp Immunol. 88:1992;499-505.
213. Karunaweera N.D., Grau G.E., Gamage P., Carter R., Mendis K.N. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci USA. 89:1992;3200-3203.
214. Katevas P., Andonopoulos A.P., Kouraklisymeonidis A., Manopoulou E., Lafi T., Makri M., Zoumbos N.C. Peripheral blood mononuclear cells from patients with rheumatoid arthritis suppress erythropoiesis in vitro via the production of tumor necrosis factor alpha. Eur J Haematol. 53:1994;26-30.
215. Kean B.H., Smith J.A. Death due to estivo-autumnal malaria: A resume of one hundred autopsy cases, 1925-1942. Am J Med. 24:1944;317-322.
216. Kelly M.T. Activation of guinea pig macrophages by Q fever rickettsiae. Cell Immunol. 28:1977;198-205.
217. Kelly M.T., Granger D.L., Ribi E., Milner K.C., Strain S.M., Stoenner H.G. Tumor regression with Q fever rickettsia and a mycobacterial glycolipid. Cancer Immunol Immunother. 1:1976;187-191.
218. Kern P., Hemmer C.J., Van Damme J., Gruss H.-J., Dietrich M. Elevated tumour necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med. 87:1989;139-143.
219. Kern P., Hemmer C.J., Gallati H., Neifer S., Kremsner P., Dietrich M., Porzsolt F. Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J Infect Dis. 166:1992;930-934.
220. Kettelhut I., Fiers W., Goldberg A.L. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. Proc Natl Acad Sci USA. 84:1987;4273-4277.
221. 2 consumption by immunostimulated Caco-2 cells. Am J Physiol. 282:2002;L1082-L1091.
222. Kilbourn R.G., Belloni P.P. Endothelial cell production of nitrogen oxides in response to interferon-γ in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst. 82:1990;772-776.
223. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide. Proc Natl Acad Sci USA. 87:1990;3629-3632.
224. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun. 172:1990;1132-1138.
225. King P., Parkin H., Macdonald I.A., Barber C., Tattersall R.B. The effect of intravenous lactate on cerebral function during hypoglycaemia. Diabet Med. 14:1997;19-28.
226. Kitchen S.F. Falciparum malaria. Boyd M.F. Malariology. 1949;966-994 W.B. Saunders, Philadelphia.
227. Knight J.C., Udalova I., Hill A., Greenwood B.M., Peshu N., Marsh K., Kwiatkowski D. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet. 22:1999;145-150.
228. Knochel J.P. Hypoxia is the cause of brain damage in hyponatremia. JAMA. 281:1999;2342-2343.
229. Koedel U., Winkler F., Angele B., Fontana T., Pfister H.W. Meningitis-associated central nervous system complications are mediated by the activation of poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab. 22:2002;39-49.
230. Kondo H., Takahashi M., Niki E. Peroxynitrite-induced hemolysis of human erythrocytes and its inhibition by antioxidants. FEBS Lett. 413:1997;236-238.
231. Kontos H.A., Wei E.P., Dietrich W.D., Navari R.M., Povlishock J.T., Ghatak N.R., Ellis E.F., Patterson J.L. Mechanism of cerebral arteriolar abnormalities after acute hypertension. Am J Physiol. 240:1981;H511-H527.
232. Koong A.C., Denko N.C., Hudson K.M., Schindler C., Swiersz L., Koch C., Evans S., Ibrahim H., Le Q.T., Terris D.J., Giaccia A.J. Candidate genes for the hypoxic tumor phenotype. Cancer Res. 60:2000;883-887.
233. Kremsner P.G., Winkler S., Wildling E., Prada J., Bienzle U., Graninger W., Nussler A.K. High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg. 90:1996;44-47.
234. Kremsner P.G., Greve B., Lell B., Luckner D., Schmid D. Malarial anaemia in African children associated with high oxygen radical production. Lancet. 355:2000;40-41.
235. Krishna S., Supanaranond W., Pukrittayakamee S., Karter D., Supputamongkol Y., Davis T.M., Holloway P.A., White N.J. Dichloroacetate for lactic acidosis in severe malaria: A pharmacokinetic and pharmacodynamic assessment. Metabolism. 43:1994;974-981.
236. Krishna S., Waller D.W., Terkuile F., Kwiatkowski D., Crawley J., Craddock C.F.C., Nosten F., Chapman D., Brewster D., Holloway P.A., White N.J. Lactic acidosis and hypoglycaemia in children with severe malaria - pathophysiological and prognostic significance. Trans R Soc Trop Med Hyg. 88:1994;67-73.
237. Krishna S., Agbenyega T., Angus B.J., Beduaddo G., Oforiamanfo G., Henderson G., Szwandt I.S.F., Obrien R., Stacpoole P.W. Pharmacokinetics and pharmacodynamics of dichloroacetate in children with lactic acidosis due to severe malaria. Q J Med. 88:1995;341-349.
238. Kristian T., Gido G., Siesjo B.K. The influence of acidosis on hypoglycemic brain damage. J Cereb Blood Flow Metab. 15:1995;78-87.
239. Kroncke K.D., Fehsel K., Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin Exp Immunol. 113:1998;147-156.
240. Kuhnle S., Nicotera P., Wendel A., Leist M. Prevention of endotoxin-induced lethality, but not of liver apoptosis, in poly(ADP-ribose) polymerase-deficient mice. Biochem Biophys Res Commun. 263:1999;433-438.
241. Kwiatkowski D., Cannon J.G., Manogue K.R., Cerami A., Dinarello C.A., Greenwood B.M. Tumor necrosis factor production in falciparum malaria and its association with schizont rupture. Clin Exp Immunol. 77:1989;361-366.
242. Kwiatkowski D., Hill A.V.S., Sambou I., Twumasi P., Castracane J., Manogue K.R., Cerami A., Brewster D.R., Greenwood B.M. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 336:1990;1201-1204.
243. Kwiatkowski D., Molyneux M.E., Stephens S., Curtis N., Klein N., Pointaire P., Smit M., Allan R., Brewster D.R., Grau G.E., Greenwood B.M. Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med. 86:1993;91-98.
244. Lanone S., Mebazaa A., Heymes C., Henin D., Poderoso J.J., Panis Y., Zedda C., Billiar T., Payen D., Aubier M., Boczkowski J. Muscular contractile failure in septic patients - role of the inducible nitric oxide synthase pathway. Am J Respir Crit Care Med. 162:2000;2308-2315.
245. Leatherman J.W., Schmitz P.G. Fever, hyperdynamic shock, and multiple-system organ failure. A pseudo-sepsis syndrome associated with chronic salicylate intoxication. Chest. 100:1991;1391-1396.
246. Leclerc C., Lamensans A., Chedid L., Drapier J.-C., Petit J.-F., Wietzerbin J., Lederer E. Nonspecific immunoprevention of L1210 leukaemia by cord factor (6-6′ dimycolate of trehalose) administered in a metabolizable oil. Cancer Immunol Immunother. 1:1976;227.
247. Lee M.D., Zentella A., Vine W., Pekala P.H., Cerami A. Effect of endotoxin-induced monokines on glucose metabolism in the muscle cell line L6. Proc Natl Acad Sci USA. 84:1987;2590-2594.
248. Leech M., Metz C., Hall P., Hutchinson P., Gianis K., Smith M., Weedon H., Holdsworth S.R., Bucala R., Morand E.F. Macrophage migration inhibitory factor in rheumatoid arthritis - evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum. 42:1999;1601-1608.
249. Lehmann L.E., Novender U., Schroeder S., Pietsch T., von Spiegel T., Putensen C., Hoeft A., Stuber F. Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis. Intensive Care Med. 27:2001;1412-1415.
250. Lemperle G. Effect of RES stimulation on endotoxin shock in mice. Proc Soc Exp Biol Med. 122:1966;1012-1015.
251. Le Page C., Sanceau J., Drapier J.C., Wietzerbin J. Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation. Biochem Biophys Res Commun. 243:1998;451-457.
252. Lewallen S., Bakker H., Taylor T.E., Wills B.A., Courtright P., Molyneux M.E. Retinal findings predictive of outcome in cerebral malaria. Trans R Soc Trop Med Hyg. 90:1996;144-146.
253. Liaudet L., Soriano F.G., Szabo E., Virag L., Mabley J.G., Salzman A.L., Szabo C. Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase. Proc Natl Acad Sci USA. 97:2000;10203-10208.
254. Liaudet L., Pacher P., Mabley J.G., Virag L., Soriano F.G., Hasko G., Szabo C. Activation of poly(ADP-ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am J Respir Crit Care Med. 165:2002;372-377.
255. Licinio J., Prolo P., McCann S.M., Wong M.L. Brain iNOS: Current understanding and clinical implications. Mol Med Today. 5:1999;225-232.
256. Looareesuwan S., Warrell D.A., White N.J., Chanthavanich P., Warrell M.J., Chantaratherakitti S., Changswek S., Chongmankongcheep L., Kanchanaranya C. Retinal hemorrhage, a common sign of prognostic significance in cerebral malaria. Am J Trop Med Hyg. 32:1983;911-915.
257. Looareesuwan S., Sjostrom L., Krudsood S., Wilairatana P., Porter R.S., Hills F., Warrell D.A. Polyclonal anti-tumor necrosis factor-alpha Fab used as an ancillary treatment for severe malaria. Am J Trop Med Hyg. 61:1999;26-33.
258. Loose L.D., Trejo R., Di Luzio N.R. Impaired endotoxin detoxification as a factor in enhanced endotoxin sensitivity of malaria infected mice. Proc Soc Exp Biol Med. 137:1971;794-797.
259. Love S., Barber R., Wilcock G.K. Neuronal accumulation of poly(ADP-ribose) after brain ischaemia. Neuropathol Appl Neurobiol. 25:1999;98-103.
260. Lucas S.B., Hounnou A., Bell J., Peacock C., Andoh J., Honde M., Decock K.M., Warrell D.A. Severe cerebral swelling is not observed in children dying with malaria. Q J Med. 89:1996;351-353.
261. Luft F.C. Lactic acidosis update for critical care clinicians. J Am Soc Nephrol. 12(Suppl. 17):2001;S15-S19.
262. Lutalo S.K., Mabuwa C. Complications of seasonal adult malaria at a central hospital. Cent Afr J Med. 36:1990;268-273.
263. Mabbott N.A., Sutherland I.A., Sternberg J.M. Trypanosoma brucei is protected from the cytostatic effects of nitric oxide under in vivo conditions. Parasitol Res. 80:1994;687-690.
264. Mabley J.G., Jagtap P., Perretti M., Getting S.J., Salzman A.L., Virag L., Szabo E., Soriano F.G., Liaudet L., Abdelkarim G.E., Hasko G., Marton A., Southan G.J., Szabo C. Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Inflamm Res. 50:2001;561-569.
265. MacGregor R.R., Sheagren J.N., Wolff S.M. Endotoxin-induced modification of Plasmodium berghei infection in mice. J Immunol. 102:1969;131-139.
266. Mackaness G.B. The immunological basis of acquired cellular resistance. J Exp Med. 120:1964;105.
267. MacPherson G.G., Warrell M.J., White N.J., Looareesuwan S., Warrell D.A. Human cerebral malaria. A quantitative ultrastructural analysis of parasitised erythrocyte sequestration. Am J Pathol. 119:1985;385-401.
268. Maegraith B.G. Meningococcal broth culture filtrates: Failure of protection experiments. Br J Exp Pathol. 19:1938;95-99.
269. Maegraith B. Pathological Processes in Malaria and Blackwater Fever. 1948;Blackwell, Oxford.
270. Maegraith B.G. Physiological aspects of protozoan infection. Annu Rev Microbiol. 8:1954;273-288.
271. Maegraith B., Fletcher A. The pathogenesis of mammalian malaria. Adv Parasitol. 10:1972;49-75.
272. Maneerat Y., Viriyavejakul P., Punpoowong B., Jones M., Wilairatana P., Pongponratn E., Turner G.D., Udomsangpetch R. Inducible nitric oxide synthase expression is increased in the brain in fatal cerebral malaria. Histopathology. 37:2000;269-277.
273. Mankowski Z.T., Yamashita M., Diller I.C. Effect of Candida guilliermondi polysaccharide on transplantable mouse sarcoma. Proc Soc Exp Biol Med. 96:1957;79.
274. Mansell P.W., DiLuzio N.R., McNamee R., Rowden G., Proctor J.W. Recognition factors and nonspecific macrophage activation in the treatment of neoplastic disease. Ann NY Acad Sci. 277:1976;20-44.
275. Manzoni O., Bockaert J. Nitric oxide synthase activity endogenously modulates NMDA receptors. J Neurochem. 61:1993;368-370.
276. Maran A., Cranston I., Lomas J., Macdonald I., Amiel S.A. Protection by lactate of cerebral function during hypoglycaemia. Lancet. 343:1994;16-20.
277. Marchiafava E., Bignami A. Sulle Febbri Estivo-Autumnali. 1894;E. Loescher, Rome.
278. Marsh K., Snow R.W. Host-parasite interaction and morbidity in malaria endemic areas. Philos Trans R Soc Lond. 352:1997;1385-1394.
279. Marsh K., Forster D., Waruiru C., Mwangi I., Winstanley M., Marsh V., Newton C., Winstanley P., Warn P., Peshu N., Pasvol G., Snow R. Indicators of life-threatening malaria in African children. N Engl J Med. 332:1995;1399-1404.
280. Marsh K., English M., Crawley J., Peshu N. The pathogenesis of severe malaria in African children. Ann Trop Med Parasitol. 90:1996;395-402.
281. Martin L.K., Einheber A., Sadun E.H., Wren R.E. Effect of bacterial endotoxin on the course of Plasmodium berghei infection. Exp Parasitol. 20:1967;186-199.
282. Martiney J.A., Sherry B., Metz C.N., Espinoza M., Ferrer A.S., Calandra T., Broxmeyer H.E., Bucala R. Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: Possible role in the pathogenesis of malarial anemia. Infect Immun. 68:2000;2259-2267.
283. Marvin H.N., Rigdon R.H. Terminal hypoglycaemia in ducks with malaria. Am J Hyg. 42:1945;174-178.
284. Masutani M., Nozaki T., Nishiyama E., Shimokawa T., Tachi Y., Suzuki H., Nakagama H., Wakabayashi K., Sugimura T. Function of poly(ADP-ribose) polymerase in response to DNA damage: Gene-disruption study in mice. Mol Cell Biochem. 193:1999;149-152.
285. Matsuda A., Tagawa Y., Matsuda H., Nishihira J. Identification and immunohistochemical localization of macrophage migration inhibitory factor in human cornea. FEBS Lett. 385:1996;225-228.
286. Mazzon E., Dugo L., De S.A., Li J.H., Caputi A.P., Zhang J., Cuzzocrea S. Beneficial effects of GPI 6150, an inhibitor of poly(ADP-ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion. Shock. 17:2002;222-227.
287. McGregor I.A., Gilles H.M., Walters J.H., Davies A.H. Effects of heavy and repeated malarial infections on Gambian infants and children. Br Med J. ii:1956;686-692.
288. McGuire W., Hill A.V.S., Allsopp C.E.M., Greenwood B.M., Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 371:1994;508-511.
289. Medana I.M., Mai N.T.H., Day N.P.J., Hien T.T., Bethell D., Phu N.H., Farrar J., White N.J., Turner G.D.H. Cellular stress and injury responses in the brains of adult Vietnamese patients with fatal Plasmodium falciparum malaria. Neuropathol Appl Neurobiol. 27:2001;421-433.
290. Medana I.M., Day N.P., Hien T.T., Mai N.T., Bethell D., Phu N.H., Farrar J., Esiri M.M., White N.J., Turner G.D. Axonal injury in cerebral malaria. Am J Pathol. 160:2002;655-666.
291. Meier S., Krause M., Luthy R., Baumann P.C., Markwalder K. Intensive care aspects in severe tropical malaria: Clinical aspects, therapy and prognostic factors. Schweiz Med Wochenschr. 125:1995;1033-1040.
292. Melillo G., Musso T., Sica A., Taylor L.S., Cox G.W., Varesio L. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med. 182:1995;1683-1693.
293. Meszaros K., Lang C.H., Bagby G.J., Spitzer J.J. Tumor necrosis factor increases in vivo glucose utilization of macrophage-rich tissues. Biochem Biophys Res Commun. 149:1987;1-6.
294. Michie H.R., Manoque K., Spriggs D., Revhaug A., O'Dwyer S., Dinarello C., Cerami A., Wolff S.M., Wilmore D.W. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 318:1988;1481-1486.
295. Mikawa K., Kodama S., Nishina K., Obara H. ONO-1714, a new inducible nitric oxide synthase inhibitor, attenuates diaphragmatic dysfunction associated with cerulein-induced pancreatitis in rats. Crit Care Med. 29:2001;1215-1221.
296. Miller K.D., White N.J., Lott J.A., Roberts J.M., Greenwood B.M. Biochemical evidence of muscle injury in African children with severe malaria. J Infect Dis. 159:1989;139-142.
297. Miller K.L., Silverman P.H., Kullgren B., Mahlmann L.J. Tumor necrosis factor alpha and the anemia associated with murine malaria. Infect Immun. 57:1989;1542-1546.
298. Miller L.H., Baruch D.I., Marsh K., Doumbo O.K. The pathogenic basis of malaria. Nature. 415:2002;673-679.
299. Misek D.E., Saltiel A.R. An inositol phosphate glycan derived from a Trypanosoma brucei glycosyl-phosphatidylinositol mimics some of the metabolic actions of insulin. J Biol Chem. 267:1992;16266-16273.
300. Molyneux M.E. Cerebral malaria in children: Clinical implications of cytoadherence. Am J Trop Med Hyg. 43:1990;38-41.
301. Molyneux M.E., Taylor T.E., Wirima J.J., Borgstein A. Clinical features and prognostic indicators in paediatric malaria: A study of 131 comatose Malawian children. Q J Med. 71:1989;441-459.
302. Molyneux M.E., Engelmann H., Taylor T.E., Wirima J.J., Aderka D., Wallach D., Grau G.E. Circulating plasma receptors for tumour necrosis factor in Malawian children with severe falciparum malaria. Cytokine. 5:1993;604-609.
303. Mortada A., Abboud I. Retinal haemorrhages after prolonged use of salicylates. Br J Ophthalmol. 57:1973;199-200.
304. Murray H.W. Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages. J Exp Med. 153:1981;1302-1315.
305. Murray H.W., Cohn Z.A. Macrophage oxygen-dependent antimicrobial activity: I. Susceptibility of Toxoplasma gondii to oxygen intermediates. J Exp Med. 150:1979;938-949.
306. Naik R.S., Branch O.H., Woods A.S., Vijaykumar M., Perkins D.J., Nahlen B.L., Lal A.A., Cotter R.J., Costello C.E., Ockenhouse C.F., Davidson E.A., Gowda D.C. Glycosylphosphatidylinositol anchors of Plasmodium falciparum: Molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J Exp Med. 192:2000;1563-1575.
307. Nathan C., Nogueira N., Juangbhanich C., Ellis J., Cohn Z. Activation of macrophages in vivo and in vitro. Correlation between hydrogen peroxide release and killing of Trypanosoma cruzi. J Exp Med. 149:1979;1056-1068.
308. Newbold C., Warn P., Black G., Berendt A., Craig A., Snow B., Msobo M., Peshu N., Marsh K. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am J Trop Med Hyg. 57:1997;389-398.
309. Newton C.R., Kirkham F.J., Winstanley P.A., Pasvol G., Peshu N., Warrell D.A., Marsh K. Intracranial pressure in African children with cerebral malaria. Lancet. 337:1991;573-576.
310. Newton C.R., Winstanley P.A., Marsh K. Retinal haemorrhages in falciparum malaria. Arch Dis Child. 66:1991;753.
311. Newton C.R., Peshu N., Kendall B., Kirkham F.J., Sowunmi A., Waruiru C., Mwangi I., Murphy S.A., Marsh K. Brain swelling and ischaemia in Kenyans with cerebral malaria. Arch Dis Child. 70:1994;281-287.
312. Newton C.R., Marsh K., Peshu N., Kirkham F.J. Perturbations of cerebral hemodynamics in Kenyans with cerebral malaria. Pediatr Neurol. 15:1996;41-49.
313. Newton C.R., Taylor T.E., Whitten R.O. Pathophysiology of fatal falciparum malaria in African children. Am J Trop Med Hyg. 58:1998;673-683.
314. Nishihira J., Koyama Y., Mizue Y. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine. 10:1998;199-205.
315. Nussler A.K., Eling W., Kremsner P.G. Patients with Plasmodium falciparum malaria and Plasmodium vivax malaria show increased nitrite and nitrate plasma levels. J Infect Dis. 169:1994;1418-1419.
316. Nyakundi J.N., Warn P., Newton C., Mumo J., Jephthahochola J. Serum tumour necrosis factor in children suffering from Plasmodium falciparum infection in Kilifi District, Kenya. Trans R Soc Trop Med Hyg. 88:1994;667-670.
317. Okitolonda W., Delacollette C., Malengreau M., Henquin J.C. High incidence of hypoglycaemia in African patients treated with intravenous quinine for severe malaria. Br Med J. 295:1987;716-718.
318. Okitsu F. Specificity of cellular immunity: The increase of resistance against various infectious diseases and tissue transplantation in zymosan-treated mice. Nippon Saikin Za. 3:1966;151-163.
319. Old L.J., Clarke D.A., Benacerraf B. Effect of bacillus Calmette-Guérin infection on transplanted tumours in the mouse. Nature. 184:1959;291-292.
320. Oliver F.J., Menissier-de Murcia J., Nacci C., Decker P., Andriantsitohaina R., Muller S., de la Rubia G., Stoclet J.C., de Murcia G. Resistance to endotoxic shock as a consequence of defective NF-κB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J. 18:1999;4446-4454.
321. Olivera W.G., Ciccolella D.E., Barquin N., Ridge K.M., Rutschman D.H., Yeates D.B., Sznajder J.I. Aldosterone regulates Na,K-ATPase and increases lung edema clearance in rats. Am J Respir Crit Care Med. 161:2000;567-573.
322. Olweny C., Chauhan S., Simooya O., Bulsara M., Njelsani E., Van Thuc H. Adult cerebral malaria in Zambia: Preliminary report of clinical findings and treatment response. J Trop Med Hyg. 89:1986;123-129.
323. Ortiz-Ortiz L., Gonzalez-Mendoza A., Lamoyi E. A vaccination procedure against Trypanosoma cruzi infection in mice by nonspecific immunization. J Immunol. 114:1975;1424-1425.
324. Overmann R.R., Hill T.S., Wong Y.T. Physiological studies in the human malarial host. J Natl Malaria Soc. 8:1949;14-31.
325. Owen-Schaub L.B., Demars M., Murphy E.C., Grimm E.A. TNF-β (lymphotoxin) strongly upregulates TNF-α-gene expression in human peripheral blood lymphocytes. Lymphokine Res. 9:1990;491-497.
326. Papadopoulos M.C., Davies D.C., Moss R.F., Tighe D., Bennett E.D. Pathophysiology of septic encephalopathy: A review. Crit Care Med. 28:2000;3019-3024.
327. Parant M., Parant F., Chedid L., Drapier J.C., Petit J.F., Wietzerbin J., Lederer E. Enhancement of nonspecific immunity to bacterial infection by cord factor (6,6′-trehalose dimycolate). J Infect Dis. 135:1977;771-777.
328. Pastuszko A., Wilson D.F., Erecinska M., Silver I.A. Effects of in vitro hypoxia and lowered pH on potassium fluxes and energy metabolism in rat brain synaptosomes. J Neurochem. 36:1981;116-123.
329. Patnaik J.K., Das B.S., Mishra S.K., Mohanty S., Satpathy S.K., Mohanty D. Vascular clogging, mononuclear cell margination, and enhanced vascular permeability in the pathogenesis of human cerebral malaria. Am J Trop Med Hyg. 51:1994;642-647.
330. Peetre C., Gullberg U., Nilsson E., Olsson I. Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. J Clin Invest. 78:1986;1694-1700.
331. Peterson W.F. Blood sugar during the crisis of malarial fever. Proc Soc Exp Biol Med. 23:1926;753-754.
332. Peyron F., Vuillez J.P., Barbe G., Boudin C., Picot S., Ambroise-Thomas P. Plasma levels of tumor necrosis factor during a longitudinal survey in an endemic area of malaria. Acta Trop. 47:1990;47-51.
333. Phillips R.E. Hypoglycaemia is an important complication of falciparum malaria. Q J Med. 71:1989;477-483.
334. Phillips R.E., Warrell D.A. The pathophysiology of severe falciparum malaria. Parasitol Today. 2:1986;271-282.
335. Pieper A.A., Verma A., Zhang J., Snyder S.H. Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci. 20:1999;171-181.
336. Pirsch J.B., Mika L.A., van der Maaten M.J. Hyperreactivity of Coxiella burnetii infected guinea pigs to subsequent injections of bacterial endotoxins. Proc Soc Exp Biol. 96:1957;376-380.
337. Playfair J.H. Toxins, cytokines, immunity and pathology. Immunol Lett. 30:1991;145-148.
338. Playfair J.H., Taverne J., Bate C.A., de Souza J.B. The malaria vaccine: Anti-parasite or anti-disease? Immunol Today. 11:1990;25-27.
339. Playfair J.H., Taverne J., Bate C.A. Don't kill the parasite: Control the disease. Acta Leiden. 60:1991;157-165.
340. Plum F., Posner J.B. Prognosis in coma. Plum F., Posner J.B. The Diagnosis of Stupor and Coma. 1980;325-334 F.A. Davis, Philadelphia.
341. Pombo D.J., Lawrence G., Hirunpetcharat C., Rzepczyk C., Bryden M., Cloonan N., Anderson K., Mahakunkijcharoen Y., Martin L.B., Wilson D. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet. 360:2002;610-617.
342. Pouvelle B., Buffet P.A., Lepolard C., Scherf A., Gysin J. Cytoadhesion of Plasmodium falciparum ring-stage-infected erythrocytes. Nat Med. 6:2000;1264-1268.
343. Prada J., Kremsner P.G. Reactive nitrogen intermediates and cerebral malaria. Trans R Soc Trop Med Hyg. 91:1997;92-93.
344. Raettig H. Provokation einer Infection durch Schutzimfung. Zentralbl Bakteriol. 174:1959;192.
345. Ringwald P., Peyron F., Vuillez J.P., Touze J.E., Lebras J., Deloron P. Levels of cytokines in plasma during Plasmodium falciparum malaria attacks. J Clin Microbiol. 29:1991;2076-2078.
346. Ringwald P., Peyron F., Lepers J.P., Rabarison P., Rakotomalala C., Razanamparany M., Rabodonirina M., Roux J., Lebras J. Parasite virulence factors during falciparum malaria - rosetting, cytoadherence, and modulation of cytoadherence by cytokines. Infect Immun. 61:1993;5198-5204.
347. Rockett K.A., Targett G.A., Playfair J.H. Killing of blood-stage Plasmodium falciparum by lipid peroxides from tumor necrosis serum. Infect Immun. 56:1988;3180-3183.
348. Rockett K.A., Awburn M.M., Cowden W.B., Clark I.A. Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect Immun. 59:1991;3280-3283.
349. Rockett K.A., Awburn M.M., Aggarwal B.B., Cowden W.B., Clark I.A. In vivo induction of nitrite and nitrate by tumor necrosis factor, lymphotoxin, and interleukin-1 - possible roles in malaria. Infect Immun. 60:1992;3725-3730.
350. Roczniak A., Burns K.D. Nitric oxide stimulates guanylate cyclase and regulates sodium transport in rabbit proximal tubule. Am J Physiol. 270:1996;F106-F115.
351. + pump ATPase of human red blood cell membranes. Biochem Pharmacol. 46:1993;525-534.
352. Rohn T.T., Hinds T.R., Vincenzi F.F. Inhibition of
353. Rojas A., Padron J., Caveda L., Palacios M., Moncada S. Role of nitric oxide pathway in the protection against lethal endotoxemia afforded by low doses of lipopolysaccharide. Biochem Biophys Res Commun. 191:1993;441-446.
354. Rubenstein M., Mulholland J.H., Jeffery G.M., Wolff S.M. Malaria-induced endotoxin tolerance. Proc Soc Exp Biol Med. 118:1965;283-287.
355. Rubinstein I., Abassi Z., Coleman R., Milman F., Winaver J., Better O.S. Involvement of nitric oxide system in experimental muscle crush injury. J Clin Invest. 101:1998;1325-1333.
356. Ruddle N.H., Waksman B.H. Cytotoxic effect of lymphocyte-antigen interaction in delayed hypersensitivity. Science. 157:1967;1060-1062.
357. Sachs J., Malaney P. The economic and social burden of malaria. Nature. 415:2002;680-685.
358. Saissy J.M., Vitris M., Diatta B., Kempf J., Adam F., Sarthou J.L. Severe malaria in African adults living in a seasonal endemic area. Intensive Care Med. 20:1994;437-441.
359. Salvin S.B., Ribi E., Granger D.L., Youngner J.S. Migration inhibitory factor and type II interferon in the circulation of mice sensitized with mycobacterial components. J Immunol. 114:1975;354-359.
360. Schild L. The ENaC channel as the primary determinant of two human diseases - Liddle syndrome and pseudohypoaldosteronism. Nephrologie. 17:1996;395-400.
361. Schmidt-Supprian M., Murphy C., While B., Lawler M., Kapurniotu A., Voelter W., Smith O., Bernhagen J. Activated protein C inhibits tumor necrosis factor and macrophage migration inhibitory factor production in monocytes. Eur Cytokine Netw. 11:2000;407-413.
362. Schoenfeld H.J., Poeschl B., Frey J.R., Loetscher H., Hunziker W., Lustig A., Zulauf M. Efficient purification of recombinant human tumor necrosis factor β from Escherichia coli yields biologically active protein with a trimeric structure that binds to both tumor necrosis factor receptors. J Biol Chem. 266:1991;3863-3869.
363. Schofield L., Hackett F. Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J Exp Med. 177:1993;145-153.
364. Schofield L., Novakovic S., Gerold P., Schwarz R.T., Mcconville M.J., Tachado S.D. Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and e-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. J Immunol. 156:1996;1886-1896.
365. Schofield L., Hewitt M.C., Evans K., Siomos M.A., Seeberger P.H. Synthetic GPI as a candidate antitoxic vaccine in a model of malaria. Nature. 418:2002;785-789.
366. Schraufstatter I.U., Hinshaw D.B., Hyslop P.A., Spragg R.G., Cochrane C.G. Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. J Clin Invest. 77:1986;1312-13120.
367. Schurr A. Lactate, glucose and energy metabolism in the ischemic brain. Int J Mol Med. 10:2002;131-136.
368. Schurr A., Payne R.S., Miller J.J., Rigor B.M. Brain lactate, not glucose, fuels the recovery of synaptic function from hypoxia upon reoxygenation: An in vitro study. Brain Res. 744:1997;105-111.
369. Senter P.D., Al-Abed Y., Metz C.N., Benigni F., Mitchell R.A., Chesney J., Han J.L., Gartner C.G., Nelson S.D., Todaro G.J., Bucala R. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites. Proc Natl Acad Sci USA. 99:2002;144-149.
370. Shah R.G., Green S., Moore M.A. Colony stimulating and inhibiting activities in mouse serum after Corynebacterium parvum-endotoxin treatment. J Reticuloendothel Soc. 23:1978;29-41.
371. Shall S. Poly (ADP-ribosylation) - a common control process? Bioessays. 24:2002;197-201.
372. Shall S., de Murcia G. Poly(ADP-ribose) polymerase-1: What have we learned from the deficient mouse model? Mutat Res. 460:2000;1-15.
373. Shindoh C., Wu D., Ohuchi Y., Kurosawa H., Kikuchi Y., Hida W., Shirato K. Effects of L-NAME and L-arginine on diaphragm contraction in a septic animal model. Comp Biochem Physiol. 119:1998;219-224.
374. Silamut K., Phu N.H., Whitty C., Turner G., Louwrier K., Mai N., Simpson J.A., Hien T.T., White N.J. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol. 155:1999;395-410.
375. Sims C.A., Wattanasirichaigoon S., Menconi M.J., Ajami A.M., Fink M.P. Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats. Crit Care Med. 29:2001;1513-1518.
376. Singh I., Kapila C.C., Khanna P.K., Nanda R.B., Rao B.D.P. High altitude pulmonary oedema. Lancet. i:1965;229-234.
377. Singh I., Khanna P.H., Srivastava M.C., Lal M., Roy S.B., Subramanyam C.S.V. Acute mountain sickness. N Engl J Med. 280:1969;175-184.
378. Sinha B., Eigler A., Baumann K.H., Greten T.F., Moeller J., Endres S. Nitric oxide downregulates tumour necrosis factor in mRNA in RAW 264.7 cells. Res Immunol. 149:1998;139-150.
379. Sloane P.J., Elsasser T.H., Spath J.A., Albertine K.H., Gee M.H. Plasma tumor necrosis factor-alpha during long-term endotoxemia in awake sheep. J Appl Physiol. 73:1992;1831-1837.
380. Smith M.E., Gunther R., Gee M., Flynn J., Demling R.H. Leukocytes, platelets, and thromboxane A2 in endotoxin-induced lung injury. Surgery. 90:1981;102-107.
381. Smith J.D., Chitnis C.E., Craig A.G., Roberts D.J., Hudson-Taylor D.E., Peterson D.S., Pinches R., Newbold C.I., Miller L.H. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell. 82:1995;101-110.
382. Smrkovski L.L., Larson C.L. Effect of treatment with BCG on the course of visceral leishmaniasis in BALB/c mice. Infect Immun. 16:1977;249-257.
383. Soriano F.G., Liaudet L., Szabo E., Virag L., Mabley J.G., Pacher P., Szabo C. Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice. Shock. 17:2002;286-292.
384. Sowunmi A. Renal function in acute falciparum malaria. Arch Dis Child. 74:1996;293-298.
385. Spitz S. The pathology of acute falciparum malaria. Milit Surg. 99:1946;555-572.
386. Spriggs D.R., Sherman M.L., Kufe D.W., Frei E. Tumour necrosis factor: Clinical trials and future directions. Ciba Foundation Symposium. vol. 131:1987;206-227 Wiley, Chichester.
387. Srichaikul T., Panikbutr N., Jeumtrakul P. Bone marrow changes in human malaria. Ann Trop Med Parasitol. 61:1967;40-51.
388. Stacpoole P.W., Wright E.C., Baumgartner T.G., Bersin R.M., Buchalter S., Curry S.H., Duncan C.A., Harman E.M., Henderson G.N., Jenkinson S.et al. A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. N Engl J Med. 327:1992;1564-1569.
389. Starnes H.F., Warren R.S., Jeevanandam M., Gabrilove J.L., Larchian W. Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest. 82:1988;1312-1325.
390. Steinmetz T., Schaadt M., Gähl R., Schenk V., Diehl V., Pfreundschuh M. Phase 1 study of 24-hour continuous intravenous infusion of recombinant human tumor necrosis factor. J Biol Response Modif. 7:1988;417-423.
391. Stettler N., Schutz Y., Whitehead R., Jequier E. Effect of malaria and fever on energy metabolism in Gambian children. Pediatr Res. 31:1992;102-106.
392. Stevens D.L., Bryant A.E., Hackett S.P., Chang A., Peer G., Kosanke S., Emerson T., Hinshaw L. Group A streptococcal bacteremia: The role of tumor necrosis factor in shock and organ failure. J Infect Dis. 173:1996;619-626.
393. Stocker R., Hunt N.H., Clark I.A., Weidemann M.J. Production of luminol-reactive oxygen radicals during Plasmodium vinckei infection. Infect Immun. 45:1984;708-712.
394. Stocker R., Hunt N.H., Buffinton G.D., Weidemann M.J., Lewis H.P., Clark I.A. Oxidative stress and protective mechanisms in erythrocytes in relation to Plasmodium vinckei load. Proc Natl Acad Sci USA. 82:1985;548-551.
395. Stocker R., Hunt N.H., Weidemann M.J., Clark I.A. Protection of vitamin E from oxidation by increased ascorbic acid content within Plasmodium vinckei-infected erythrocytes. Biochim Biophys Acta. 876:1986;294-299.
396. Stuehr D.J., Nathan C.F. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med. 169:1989;1543-1555.
397. Suter E., Kirsanow E.M. Hyperreactivity to endotoxin in mice infected with Mycobacterium. Induction and elicitation of the reaction. Immunology. 4:1961;354-365.
398. Suter E., Ullman G.E., Hoffman R.G. Sensitivity of mice to endotoxin after vaccination with BCG (bacillus Calmette-Guérin). Proc Soc Exp Biol. 99:1958;167-169.
399. Swartzberg J.E., Krahenbuhl J.L., Remington J.S. Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Corynebacterium parvum. Infect Immun. 12:1975;1037-1043.
400. Szabo C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock. 6:1996;79-88.
401. Takahashi K., Pieper A.A., Croul S.E., Zhang J., Snyder S.H., Greenberg J.H. Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia. Brain Res. 829:1999;46-54.
402. Takahashi M., Nishihira J., Shimpo M., Mizue Y., Ueno S., Mano H., Kobayashi E., Ikeda U., Shimada K. Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes. Cardiovasc Res. 52:2001;438-445.
403. Takei Y., Takashima S., Ohyu J., Takami T., Miyajima T., Hoshika A. Effects of nitric oxide synthase inhibition on the cerebral circulation and brain damage during kainic acid-induced seizures in newborn rabbits. Brain Develop. 21:1999;253-259.
404. Taliaferro W.H., Cannon P.R. The cellular reactions during primary infections and super-infections of Plasmodium brasilianum in Panamanian monkeys. J Infect Dis. 59:1936;72-125.
405. Taliaferro W.H., Taliaferro L.G. Morphology, periodicity and course of infection of Plasmodium brasilianum in Panamanian monkeys. Am J Hyg. 20:1934;60-72.
406. Taliaferro W.H., Taliaferro L.G. The effect of immunity on the asexual reproduction of Plasmodium brasilianum. J Infect Dis. 75:1944;1-32.
407. Tanaka K., Gotoh F., Gomi S., Takashima S., Mihara B., Shirai T., Nogawa S., Nagata E. Inhibition of nitric oxide synthesis induces a significant reduction in local cerebral blood flow in the rat. Neurosci Lett. 127:1991;129-132.
408. Taverne J., Tavernier J., Fiers W., Playfair J.H.L. Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro. Clin Exp Immunol. 67:1987;1-4.
409. Taverne J., Bate C.A.W., Playfair J.H.L. Induction of TNF in vitro as a model for the identification of toxic malaria antigens. Lymphokine Res. 8:1989;317-322.
410. Taverne J., Bate C.A., Kwiatkowski D., Jakobsen P.H., Playfair J.H. Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages. Infect Immun. 58:1990;2923-2928.
411. Taverne J., Bate C.A., Playfair J.H. Malaria exoantigens induce TNF, are toxic and are blocked by T-independent antibody. Immunol Lett. 25:1990;207-212.
412. Taverne J., Sheikh N., Desouza J.B., Playfair J.H.L., Probert L., Kollias J. Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor. Immunology. 82:1994;397-403.
413. Tawadrous Z.S., Delude R.L., Fink M.P. Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats. Shock. 17:2002;473-477.
414. Taylor F.B. Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: Examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants. Crit Care Med. 29:2001;S78-S89.
415. Taylor D.J., Whitehead R.J., Evanson J.M., Westmacott D., Feldmann M., Bertfield H., Morris M.A., Woolley D.E. Effect of recombinant cytokines on glycolysis and fructose 2,6-bisphosphate in rheumatoid synovial cells in vitro. Biochem J. 250:1988;111-115.
416. Taylor T.E., Molyneux M.E., Wirima J.J., Fletcher K.A., Morris K. Blood glucose levels in Malawian children before and during the administration of intravenous quinine for severe falciparum malaria. N Engl J Med. 319:1988;1040-1047.
417. Taylor K., Bate C.A.W., Carr R.E., Butcher G.A., Taverne J., Playfair J.H.L. Phospholipid-containing toxic malaria antigens induce hypoglycaemia. Clin Exp Immunol. 90:1992;1-5.
418. Taylor T.E., Borgstein A., Molyneux M.E. Acid-base status in paediatric Plasmodium falciparum malaria. Q J Med. 86:1993;99-109.
419. Tokime T., Nozaki K., Sugino T., Kikuchi H., Hashimoto N., Ueda K. Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain. J Cereb Blood Flow Metab. 18:1998;991-997.
420. Tracey K.J., Beutler B., Lowry S.F., Merryweather J., Wolpe S., Milsark I.W., Hariri R.J., Fahey T.J., Zentella A., Albert J.D., Shires G.T., Cerami A. Shock and tissue injury induced by recombinant human cachectin. Science. 234:1986;470-474.
421. Tracey K.J., Fong Y., Hesse D.G., Manogue K.R., Lee A.T., Kuo G.C., Lowry S.F., Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal shock bacteraemia. Nature. 330:1987;662-664.
422. Tracey K.J., Lowry S.F., Fahey T.J., Albert J.D., Fong Y., Hesse D., Beutler B., Manogue K.R., Calvano S., Cerami A., Shires G.T. Cachectin/tumor necrosis factor induces lethal shock and stress hormone response in the dog. Surg Gynecol Obstet. 164:1987;415-422.
423. Trenholme K.R., Gardiner D.L., Holt D.C., Thomas E.A., Cowman A.F., Kemp D.J. clag9: A cytoadherence gene in Plasmodium falciparum essential for binding of parasitized erythrocytes to CD36. Proc Natl Acad Sci USA. 97:2000;4029-4033.
424. Turner G.D.H., Vanchuong L., Mai N.T.H., Chau T.T.H., Phu N.H., Bethell D., Wyllie S., Louwrier K., Fox S.B., Gatter K.C., Day N.P., Hien T.T., White N.J., Berendt A.R. Systemic endothelial activation occurs in both mild and severe malaria: Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. Am J Pathol. 152:1998;1477-1487.
425. Ulloa L., Ochani M., Yang H., Tanovic M., Halperin D., Yang R., Czura C.J., Fink M.P., Tracey K.J. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA. 99:2002;12351-12356.
426. VanderMeer T.J., Wang H., Fink M.P. Endotoxemia causes ileal mucosal acidosis in the absence of mucosal hypoxia in a normodynamic porcine model of septic shock. Crit Care Med. 23:1995;1217-1226.
427. Van Hensbroek M.B., Palmer A., Onyiorah E., Schneider G., Jaffar S., Dolan G., Memming H., Frenkel J., Enwere G., Bennett S., Kwiatkowski D., Greenwood B. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis. 174:1996;1091-1097.
428. Voulgari P.V., Kolios G., Papadopoulos G.K., Katsaraki A., Seferiadis K., Drosos A.A. Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis. Clin Immunol. 92:1999;153-160.
429. Waage A., Halstensen A., Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. i:1987;355-357.
430. Wakabayashi Y., Kikawada R. Effect of L-arginine on myoglobin-induced acute renal failure in the rabbit. Am J Physiol. 270:1996;F784-F789.
431. Waller D., Crawley J., Nosten F., Chapman D., Krishna S., Craddock C., Brewster D., White N.J. Intracranial pressure in childhood cerebral malaria. Trans R Soc Trop Med Hyg. 85:1991;362-364.
432. Wambach G., Overhoff U., Hossmann V. Sodium transport and red cell deformability. Klin Wochenschr. 3(Suppl. 3):1985;35-37.
433. Wang Z.Q., Stingl L., Morrison C., Jantsch M., Los M., Schulze Osthoff K., Wagner E.F. PARP is important for genomic stability but dispensable in apoptosis. Genes Dev. 11:1997;2347-2358.
434. Wang H.C., Bloom O., Zhang M.H., Vishnubhakat J.M., Ombrellino M., Che J.T., Frazier A., Yang H., Ivanova S., Borovikova L., Manogue K.R., Faist E., Abraham E., Andersson J., Andersson U., Molina P.E., Abumrad N.N., Sama A., Tracey K.J. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 285:1999;248-251.
435. Warden G.D., Wilmore D.W., Rogers P.W., Mason A.D., Pruitt B.A. Hypernatremic state in hypermetabolic burn patients. Arch Surg. 106:1973;420-427.
436. Warrell D.A. Pathophysiology of severe falciparum malaria in man. Parasitology. 94:1987;S53-S76. (Suppl.).
437. Warrell D.A., Perine P.L., Bryceson A.D., Parry E.H., Pope H.M. Physiologic changes during the Jarisch-Herxheimer reaction in early syphilis. A comparison with louse-borne relapsing fever. Am J Med. 51:1971;176-185.
438. Warrell D.A., Looareesuwan S., Warrell M.J., Kasemsarn P., Intaraprasert R., Bunnag D., Harinasuta T. Dexamethasone proves deleterious in cerebral malaria; a double-blind trial in 100 comatose patients. N Engl J Med. 306:1982;313-319.
439. Warrell D.A., Veall N., Chanthanavich P., Karbwang J., White N.J., Looareesuwan S., Phillips R.E., Pongpaew P. Cerebral anaerobic glycolysis and reduced cerebral oxygen transport in human malaria. Lancet. ii:1988;534-538.
440. Weber M.W., Boker K., Horstmann R.D., Ehrich J.H. Renal failure is a common complication in non-immune Europeans with Plasmodium falciparum malaria. Trop Med Parasitol. 42:1991;115-118.
441. Weidanz W.P., Grun J.L. Antibody-independent mechanisms in the development of acquired immunity to malaria. Adv Exp Med Biol. 162:1983;409-423.
442. Weinberg J.B. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: A review. Mol Med. 4:1998;557-591.
443. Weinblatt M.E., Kremer J.M., Bankhurst A.D., Bulpitt K.J., Fleischmann R.M., Fox R.I., Jackson C.G., Lange M., Burge D.J. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med. 340:1999;253-259.
444. Weiss L. The red pulp of the spleen: Structural basis of blood flow. Clin Haematol. 12:1983;375-393.
445. Weiss G., Thuma P.E., Biemba G., Mabeza G., Werner E.R., Gordeuk V.R. Cerebrospinal fluid levels of biopterin, nitric oxide metabolites, and immune activation markers and the clinical course of human cerebral malaria. J Infect Dis. 177:1998;1064-1068.
446. Whalen M.J., Clark R.S., Dixon C.E., Robichaud P., Marion D.W., Vagni V., Graham S., Virag L., Hasko G., Stachlewitz R., Szabo C., Kochanek P.M. Traumatic brain injury in mice deficient in poly-ADP(ribose) polymerase: a preliminary report. Acta Neurochir. 76:2000;61-64. (Suppl.).
447. White N.J., Ho M. The pathophysiology of malaria. Adv Parasitol. 31:1992;83-173.
448. White N.J., Warrell D.A., Looareesuwan S., Chanthavanich P., Phillips R.E., Pongpaew P. Pathophysiological and prognostic significance of cerebrospinal fluid lactate in cerebral malaria. Lancet. i:1985;776-778.
449. White N.J., Marsh K., Turner R.C., Miller K.D., Berry C.D., Wiliamson D.H., Brown J. Hypoglycaemia in African children with severe malaria. Lancet. i:1987;708-711.
450. White V.A., Lewallen S., Beare N., Kayira K., Carr R.A., Taylor T.E. Correlation of retinal haemorrhages with brain haemorrhages in children dying of cerebral malaria in Malawi. Trans R Soc Trop Med Hyg. 95:2001;618-621.
451. WHO Severe and complicated malaria. Trans R Soc Trop Med Hyg. 80:1986;3-49. (Suppl.).
452. Wickramasinghe S.N., Phillips R.E., Looareesuwan S., Warrell D.A., Hughes M. The bone marrow in human cerebral malaria: Parasite sequestration within sinusoids. Br J Haematol. 66:1987;295-306.
453. Wickramasinghe S.N., Looareesuwan S., Nagachinta B., White N.J. Dyserythropoiesis and ineffective erythropoiesis in Plasmodium vivax malaria. Br J Haematol. 72:1989;91-99.
454. Wozencraft A.O., Dockrell H.M., Taverne J., Targett G.A., Playfair J.H. Killing of human malaria parasites by macrophage secretory products. Infect Immun. 43:1984;664-669.
455. Yang R., Gallo D.J., Baust J.J., Uchiyama T., Watkins S.K., Delude R.L., Fink M.P. Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock. Am J Physiol. 283:2002;G212-G221.
456. Yasmeen D., Laird A.J., Hume D.A., Weidemann M.J. Activation of 3-O-methyl-glucose transport in rat thymus lymphocytes by concanavalin A. Temperature and calcium ion dependence and sensitivity to puromycin but not to cycloheximide. Biochim Biophys Acta. 500:1977;89-102.
457. Ye Z.C., Sontheimer H. Cytokine modulation of glial glutamate uptake: A possible involvement of nitric oxide. NeuroReport. 7:1996;2181-2185.
458. Youdim S. Cooperation of immune lymphoid and reticuloendothelial cells during Listeria monocytogenes-mediated tumor immunity. Cancer Res. 37:1977;991-996.
459. ras. Proc Natl Acad Sci USA. 95:1998;5773-5778.
460. Zauner C., Gendo A., Kramer L., Funk G.C., Bauer E., Schenk P., Ratheiser K., Madl C. Impaired subcortical and cortical sensory evoked potential pathways in septic patients. Crit Care Med. 30:2002;1136-1139.
461. Zentella A., Manogue K., Cerami A. Cachectin/TNF-mediated lactate production in cultured myocytes is linked to activation of a futile substrate cycle. Cytokine. 5:1993;436-447.
462. Zingarelli B., Halushka P.V., Caputi A.P., Cook J.A. Increased nitric oxide synthesis during the development of endotoxin tolerance. Shock. 3:1995;102-108.
463. Zingarelli B., Makhlouf M., Halushka P.V., Caputi A.P., Cook J.A. Altered macrophage function in tumor necrosis factor alpha- and endotoxin-induced tolerance. J Endotoxin Res. 2:1995;247-254.
464. Zingarelli B., Hake P.W., Cook J.A. Inducible nitric oxide synthase is not required in the development of endotoxin tolerance in mice. Shock. 17:2002;478-484.
465. Zinkernagel R.M. Cell-mediated immune response to Salmonella typhimurium infection in mice: Development of nonspecific bactericidal activity against Listeria monocytogenes. Infect Immun. 13:1976;1069-1073.
466. Zweifach B.W., Thomas L. The relationship between the vascular manifestations of shock produced by endotoxin, trauma, and hemorrhage. J Exp Med. 106:1957;385-401.